title: Tuberculosis drug resistance in England and Wales. How much is 'home-grown'?
abstract: The fact that a substantial proportion of tuberculosis drug resistance (especially multidrug resistance) is due to transmission of resistant strains or treatment failure in the UK underlines the need to strengthen control in this country. Early identification and effective treatment of cases (including measures to support adherence and appropriate use of initial treatment regimes involving at least four drugs in those at risk of isoniazid resistance) would help to control the problem [1].
authors: Public Health Laboratory Service, Communicable Disease Surveillance Centre, London, UK.
authors: A C
authors: AC
authors: Hayward
authors: J
authors: J
authors: Herbert
authors: J M
authors: JM
authors: Watson
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D004739:England; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000494:pharmacology*; D010818:Practice Patterns, Physicians'; D011634:Public Health; D012307:Risk Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014852:Wales
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid